Kimia Farma Persero Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as wel… Read more
Kimia Farma Persero Tbk (KAEF) - Net Assets
Latest net assets as of June 2025: Rp3.07 Trillion IDR
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has net assets worth Rp3.07 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp14.97 Trillion) and total liabilities (Rp11.91 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp3.07 Trillion |
| % of Total Assets | 20.49% |
| Annual Growth Rate | 7.65% |
| 5-Year Change | -51.75% |
| 10-Year Change | 84.14% |
| Growth Volatility | 29.12 |
Kimia Farma Persero Tbk - Net Assets Trend (2002–2024)
This chart illustrates how Kimia Farma Persero Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Kimia Farma Persero Tbk (2002–2024)
The table below shows the annual net assets of Kimia Farma Persero Tbk from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp3.43 Trillion | -46.36% |
| 2023-12-31 | Rp6.39 Trillion | -31.55% |
| 2022-12-31 | Rp9.34 Trillion | +29.14% |
| 2021-12-31 | Rp7.23 Trillion | +1.78% |
| 2020-12-31 | Rp7.11 Trillion | -4.14% |
| 2019-12-31 | Rp7.41 Trillion | +120.86% |
| 2018-12-31 | Rp3.36 Trillion | +30.47% |
| 2017-12-31 | Rp2.57 Trillion | +13.26% |
| 2016-12-31 | Rp2.27 Trillion | +21.98% |
| 2015-12-31 | Rp1.86 Trillion | +2.81% |
| 2014-12-31 | Rp1.81 Trillion | +11.50% |
| 2013-12-31 | Rp1.62 Trillion | +12.68% |
| 2012-12-31 | Rp1.44 Trillion | +15.09% |
| 2011-12-31 | Rp1.25 Trillion | +12.43% |
| 2010-12-31 | Rp1.11 Trillion | +11.93% |
| 2009-12-31 | Rp995.32 Billion | +5.02% |
| 2008-12-31 | Rp947.76 Billion | +4.38% |
| 2007-12-31 | Rp908.03 Billion | +4.29% |
| 2006-12-31 | Rp870.65 Billion | +3.13% |
| 2005-12-31 | Rp844.22 Billion | +3.64% |
| 2004-12-31 | Rp814.58 Billion | +7.97% |
| 2003-12-31 | Rp754.46 Billion | +11.39% |
| 2002-12-31 | Rp677.30 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Kimia Farma Persero Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14605.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rp556.66 Billion | 24.27% |
| Other Comprehensive Income | Rp8.66 Trillion | 377.72% |
| Total Equity | Rp2.29 Trillion | 100.00% |
Kimia Farma Persero Tbk Competitors by Market Cap
The table below lists competitors of Kimia Farma Persero Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Strategic Minerals Plc
PINK:SMCDF
|
$16.65 Million |
|
Steamships Trading Company Ltd
AU:SST
|
$16.65 Million |
|
OpenSys M Bhd
KLSE:0040
|
$16.66 Million |
|
T Scientific Co.Ltd
KQ:057680
|
$16.66 Million |
|
Hove AS
CO:HOVE
|
$16.64 Million |
|
Pierre & Vacances
LSE:0OQ0
|
$16.64 Million |
|
Innovative Technology Development Corp
VN:ITD
|
$16.64 Million |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
$16.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kimia Farma Persero Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,888,061,604,000 to 2,293,469,732,000, a change of -3,594,591,872,000 (-61.0%).
- Net loss of 842,272,199,000 reduced equity.
- Dividend payments of 78,623,000 reduced retained earnings.
- Other comprehensive income increased equity by 162,947,837,000.
- Other factors decreased equity by 2,915,188,887,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp-842.27 Billion | -36.72% |
| Dividends Paid | Rp78.62 Million | -0.0% |
| Other Comprehensive Income | Rp162.95 Billion | +7.1% |
| Other Changes | Rp-2.92 Trillion | -127.11% |
| Total Change | Rp- | -61.05% |
Book Value vs Market Value Analysis
This analysis compares Kimia Farma Persero Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.22x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.80x to 1.22x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | Rp170.65 | Rp478.00 | x |
| 2009-12-31 | Rp179.21 | Rp478.00 | x |
| 2010-12-31 | Rp200.58 | Rp478.00 | x |
| 2011-12-31 | Rp225.51 | Rp478.00 | x |
| 2012-12-31 | Rp256.84 | Rp478.00 | x |
| 2013-12-31 | Rp289.56 | Rp478.00 | x |
| 2014-12-31 | Rp322.15 | Rp478.00 | x |
| 2015-12-31 | Rp330.58 | Rp478.00 | x |
| 2016-12-31 | Rp399.88 | Rp478.00 | x |
| 2017-12-31 | Rp451.98 | Rp478.00 | x |
| 2018-12-31 | Rp576.52 | Rp478.00 | x |
| 2019-12-31 | Rp1303.91 | Rp478.00 | x |
| 2020-12-31 | Rp1259.16 | Rp478.00 | x |
| 2021-12-31 | Rp1285.50 | Rp478.00 | x |
| 2022-12-31 | Rp1285.13 | Rp478.00 | x |
| 2023-12-31 | Rp1060.15 | Rp478.00 | x |
| 2024-12-31 | Rp391.23 | Rp478.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kimia Farma Persero Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -36.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.47%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 6.53x
- Recent ROE (-36.72%) is below the historical average (4.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 5.23% | 2.30% | 1.48x | 1.53x | Rp-32.32 Billion |
| 2003 | 5.69% | 2.36% | 1.33x | 1.81x | Rp-32.52 Billion |
| 2004 | 10.13% | 4.28% | 1.64x | 1.44x | Rp1.06 Billion |
| 2005 | 6.26% | 2.91% | 1.54x | 1.39x | Rp-31.60 Billion |
| 2006 | 5.05% | 2.01% | 1.74x | 1.45x | Rp-43.08 Billion |
| 2007 | 5.75% | 2.21% | 1.71x | 1.53x | Rp-38.61 Billion |
| 2008 | 5.84% | 2.05% | 1.87x | 1.53x | Rp-39.38 Billion |
| 2009 | 6.28% | 2.19% | 1.83x | 1.57x | Rp-37.02 Billion |
| 2010 | 12.45% | 4.36% | 1.92x | 1.49x | Rp27.31 Billion |
| 2011 | 13.71% | 4.93% | 1.94x | 1.43x | Rp46.52 Billion |
| 2012 | 14.38% | 5.49% | 1.80x | 1.46x | Rp62.48 Billion |
| 2013 | 13.34% | 4.93% | 1.76x | 1.54x | Rp53.73 Billion |
| 2014 | 13.11% | 5.19% | 1.52x | 1.66x | Rp55.70 Billion |
| 2015 | 13.55% | 5.12% | 1.50x | 1.76x | Rp65.24 Billion |
| 2016 | 12.04% | 4.60% | 1.26x | 2.08x | Rp45.32 Billion |
| 2017 | 13.02% | 5.33% | 1.01x | 2.43x | Rp75.76 Billion |
| 2018 | 12.99% | 5.58% | 0.79x | 2.95x | Rp95.70 Billion |
| 2019 | -0.18% | -0.14% | 0.51x | 2.53x | Rp-736.91 Billion |
| 2020 | 0.25% | 0.18% | 0.57x | 2.51x | Rp-681.70 Billion |
| 2021 | 4.23% | 2.35% | 0.72x | 2.49x | Rp-411.69 Billion |
| 2022 | -2.67% | -2.06% | 0.45x | 2.85x | Rp-904.24 Billion |
| 2023 | -25.23% | -14.91% | 0.57x | 2.99x | Rp-2.07 Trillion |
| 2024 | -36.72% | -8.47% | 0.66x | 6.53x | Rp-1.07 Trillion |
Industry Comparison
This section compares Kimia Farma Persero Tbk's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,484,263,699,829
- Average return on equity (ROE) among peers: 8.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kimia Farma Persero Tbk (KAEF) | Rp3.07 Trillion | 5.23% | 3.88x | $16.65 Million |
| Enseval Putra Megatrading Tbk (EPMT) | $5.13 Trillion | 10.09% | 0.45x | $31.13 Million |
| Itama Ranoraya (IRRA) | $512.31 Billion | 10.40% | 2.24x | $4.89 Million |
| PT Medela Potentia Tbk (MDLA) | $1.71 Trillion | 18.29% | 1.59x | $130.48 |
| Millennium Pharmacon International (SDPC) | $282.50 Billion | 5.99% | 5.27x | $1.76 Million |
| PT Soho Global Health Tbk (SOHO) | $1.21 Trillion | 4.10% | 1.31x | $138.50 Million |
| Dosni Roha Indonesia Tbk PT (ZBRA) | $69.73 Billion | 1.21% | 0.95x | $1.64 Million |